Trial Profile
Open-label, within-subject controlled, Phase IIa study to investigate repeat dose antimicrobial photodynamic therapy in patients with acne vulgaris.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2011
Price :
$35
*
At a glance
- Drugs PPA 904 (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Photopharmica
- 22 Jun 2011 New trial record